Skip to main content
Article
Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience
The Journal of Thoracic and Cardiovascular Surgery (2016)
  • Candice L. Wilshire, Division of Thoracic Surgery, Swedish Cancer Institute, Seattle, Wash
  • Brian E. Louie, Division of Thoracic Surgery, Swedish Cancer Institute, Seattle, Wash
  • Matthew P. Horton, CellNetix Pathology and Laboratories, Seattle, Wash
  • Massimo Castiglioni, Division of Thoracic Surgery, Swedish Cancer Institute, Seattle, Wash
  • Ralph W. Aye, Division of Thoracic Surgery, Swedish Cancer Institute, Seattle, Wash
  • Alexander S. Farivar, Division of Thoracic Surgery, Swedish Cancer Institute, Seattle, Wash
  • Howard L. West, Division of Medical Oncology, Swedish Cancer Institute, Seattle, Wash
  • Jed A. Gorden, Division of Thoracic Surgery, Swedish Cancer Institute, Seattle, Wash
  • Eric Vallières, Division of Thoracic Surgery, Swedish Cancer Institute, Seattle, Wash
Publication Date
June 1, 2016
DOI
10.1016/j.jtcvs.2016.01.029
Citation Information
Candice L. Wilshire, Brian E. Louie, Matthew P. Horton, Massimo Castiglioni, et al.. "Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience" The Journal of Thoracic and Cardiovascular Surgery Vol. 151 Iss. 6 (2016) p. 1561 - 1568
Available at: http://works.bepress.com/brian-louie/106/